STOCK MARKET BSE NSE

DCGI gives nod to India's first fully indigenously developed vaccine against pneumonia

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India.

Published: 15th July 2020 08:30 PM  |   Last Updated: 15th July 2020 08:30 PM   |  A+A-

DCGI gives nod to India's first fully indigenously developed vaccine against pneumonia

The vaccine is administered in an intramuscular manner. (Representational Image)

By PTI

NEW DELHI: The country's first fully indigenously developed vaccine against pneumonia has got approval from the Drug Controller General of India (DCGI), the Union health ministry said on Wednesday.

With the help of Special Expert Committee (SEC) for vaccines, the drug regulator reviewed the phase I, II and III clinical trial data submitted by Pune-based firm Serum Institute of India and then granted the market approval for Pneumococcal Polysaccharide Conjugate Vaccine.

The vaccine is administered in an intramuscular manner.

The ministry said the vaccine will be used for active immunisatiuon against invasive disease and pneumonia caused by 'Streptococcus pneumonia' among infants.

ALSO READ | WHO 'concerned' about rising pneumonia cases in Turkmenistan

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India.

These trials have since been concluded within the country. The company also conducted the clinical trials in Gambia.

Thereafter, the company applied for approval and permission to manufacture the vaccine.

ALSO READ | WHO believes 'unknown pneumonia' in Kazakhstan could be COVID-19

The Special Expert Committee (SEC) recommended for grant of permission of market authorization to the said vaccine.

On July 14, Serum Institute of India Pvt Ltd was granted permission to manufacture domestically developed first Pneumococcal Polysaccharide Conjugate Vaccine, the ministry said.

"This is the first indigenously developed vaccine in the field of pneumonia," it said.

Earlier, the demand of such vaccine was substantially met by licensed importers in the country since the manufacturers were all vaccine companies based outside India, the ministry added.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments(1)

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

  • m.abhishek

    covid
    15 days ago reply
flipboard facebook twitter whatsapp